U.S. Court of Appeals for the Federal Circuit
Valeant Pharmaceuticals v. Mylan Pharmaceuticals
This writing
- Type
- Opinion
- Filed
- Nov. 5, 2020
- Case
- Valeant Pharmaceuticals v. Mylan Pharmaceuticals
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 19-2402 Document: 72 Page: 1 Filed: 11/05/2020 United States Court of Appeals for the Federal Circuit ______________________ VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND LTD., DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN INC., Defendan…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.